| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498330 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498146 Containing high-molecular vWF multimers and being free from low-molecular vWF molecules and proteolytic vWF degradation products; chromatographic purification of Factor VIII or a Factor VIII/vWF-complex, admixing a purified high-molecular fraction of vWF molecules; hemophilia A, von Willebrand Disease |
| 03/03/2009 | US7498045 Biodegradable polymeric nanocapsules and uses thereof |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 02/26/2009 | WO2009026276A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | WO2009025957A1 Erythropoietin receptor peptide formulations and uses |
| 02/26/2009 | WO2009024653A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 02/26/2009 | WO2009024571A1 Blood coagulation factor inhibitors |
| 02/26/2009 | WO2008137084A3 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 02/26/2009 | US20090054499 results in little or no liver damage |
| 02/26/2009 | US20090054488 Isomigrastatin Analogs In The Treatment Of Cancer |
| 02/26/2009 | US20090054425 Protein kinase inhibitors |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054356 1-substituted-7-(b-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 02/26/2009 | US20090054343 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | US20090053791 Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
| 02/26/2009 | US20090053288 Hemostatic woven fabric |
| 02/26/2009 | US20090053242 Thrombopoietic compounds |
| 02/26/2009 | US20090053182 Endometrial stem cells and methods of making and using same |
| 02/26/2009 | US20090053173 Stabilization of such as human interleukin 11; reduced toxicity; cost effective; shelf life; SARS virus, HIV, HCV, HBV, or HAV, and the cancer diseases, such as leukemia and malignant melanoma; between a human serum albumin and an Interferon |
| 02/26/2009 | CA2734549A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 02/26/2009 | CA2697081A1 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/25/2009 | EP2028191A1 Peptides and compounds that bind to a receptor |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/25/2009 | EP2026810A2 Compositions and methods for modulating the immune system |
| 02/25/2009 | EP2026801A2 Method of treatment of hereditary hemochromatosis |
| 02/25/2009 | EP2026778A2 Use of a rar antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects |
| 02/25/2009 | EP2026743A1 Paste for use as a bandage on mucous membranes of the oral cavity or on the skin |
| 02/25/2009 | EP2026653A2 Administration of the reg1 anticoagulation system |
| 02/25/2009 | EP1459758B1 Cofilin for promoting the proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |
| 02/25/2009 | EP1365651A4 Composition and methods for modulation of vascular structure and/or function |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101375160A Potentiation of apoptosis by monoclonal antibodies |
| 02/25/2009 | CN101374815A Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
| 02/25/2009 | CN101374540A Purpose of TPO peptide compound and medicament composition for treating anaemia |
| 02/25/2009 | CN101372513A SG fusion protein |
| 02/25/2009 | CN101372512A Anticoagulated blood polypeptides and uses thereof |
| 02/25/2009 | CN101371924A Therapy of autoimmune disease in a patient with an inadequate response to a TNF-ALPHA inhibitor |
| 02/25/2009 | CN101371921A Instant lyophilized fibrinogen and fibrin ferment formulation composition, preparation method and use thereof |
| 02/25/2009 | CN101371920A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 02/25/2009 | CN101371893A Pollen hydragogue medicine |
| 02/25/2009 | CN101371869A Inhibitor originated from alpha-glucosidase of natto and preparation method thereof |
| 02/25/2009 | CN101371868A Chinese medicine preparation for treating aplastic anemia |
| 02/25/2009 | CN101371847A Use of pseudo ginsengenin in preparing medicament for resisting platelet aggregation |
| 02/25/2009 | CN100463692C Chinses medicinal capsule for treating aplastic anemia |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7494973 Therapeutic fibrin-derived peptides and uses thereof |
| 02/24/2009 | US7494824 Interactive system for presenting and eliminating substances |
| 02/24/2009 | US7494807 Nutrient broth for propagation of hematopoietic stem cells |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2297406C Tricyclic vasopressin agonists |
| 02/19/2009 | WO2009023233A1 Substituted oxazolidinone derivatives |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009022417A1 Peritoneal dialysate |
| 02/19/2009 | WO2009022399A1 Novel microorganism having gastric juice promoting action and composition secreted by the same |
| 02/19/2009 | WO2008130600A3 Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| 02/19/2009 | US20090048307 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048231 Substituted prolinamides, the preparation thereof and the use thereof as pharmaceutical compositions |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048150 Materials and Methods for the Detection of Nitrated Fibrinogen |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047366 Inorganic Coagulation Accelerators for Individuals taking Platelet Blockers or Anticoagulants |
| 02/19/2009 | US20090047284 Methods and compositions for PDGF-C activation and inhibition |
| 02/19/2009 | US20090047281 Activin-ActRII antagonists and uses for increasing red blood cell levels |
| 02/19/2009 | US20090047273 Method For Production of Recombinant Human Thrombin ['644] |
| 02/19/2009 | US20090047251 Conjugates of hydroxyalkyl starch and a protein |
| 02/19/2009 | DE102007037373A1 New oxazolidinone derivatives are factor Xa inhibitors useful to treat e.g. acute coronary syndrome, myocardial infarction, angina pectoris, reocclusion, restenosis, stroke, artrial fibrillation, arrhythmia and blood clotting disorder |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2695176A1 Peritoneal dialysate |
| 02/18/2009 | EP2025671A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
| 02/18/2009 | EP2024361A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof |
| 02/18/2009 | EP2023913A2 Methods for treating blood disorders |
| 02/18/2009 | EP2023912A2 Methods and compositions using immunomodulatory compounds in combination therapy |
| 02/18/2009 | EP1682167B1 Use of hyperpolymer haemoglobin for treating a pulmonary oedema |
| 02/18/2009 | EP1539727B1 Compounds, compositions, and methods for treating cellular proliferative diseases |
| 02/18/2009 | EP1458757B1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | CN101368180A Small RNA numerator for differentiation of mesenchyma stem cell into hematopoiesis cell and function target point thereof |
| 02/18/2009 | CN101367881A High-efficiency preparation method for glossy ganoderma polysaccharide |
| 02/18/2009 | CN101366916A Chinese medicinal composition of embolism extinguishing medicinal granules |
| 02/18/2009 | CN100462367C Amidated horseshoe crab anti-endotoxin factor circular analogue peptide molecule, its synthetic method and use |
| 02/18/2009 | CN100462366C Amidated horseshoe crab anti endotoxin factor linear analogue peptide molecule, its synthetic method and use |
| 02/18/2009 | CN100462351C Amino acids with affinity for the alpha-2-delta-protein |
| 02/18/2009 | CN100462081C Preparing method for intermediate of perennial sowthistle |
| 02/18/2009 | CN100462073C Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
| 02/18/2009 | CN100462067C Preparation method of sodium iron chlorophyllin-ethyl cellulose microcapsule |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | US7491550 Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) |